Excellent
Fully Aligned
Patient Risk:
Low
Summary
The AI-generated claims for MIEBO’s indicated use (DED) and dosing (one drop four times daily into affected eye(s)) are directly supported by the provided prescribing information excerpts (Sections 1 and 2.1).
Category Scores
Accurate Statements
MIEBO is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
Supported by Label Section 1 INDICATIONS AND USAGE: “MIEBO … is indicated for the treatment of the signs and symptoms of dry eye disease (DED).”
MIEBO is dosed as one drop four times daily into affected eye(s).
Supported by Label Section 2.1 Recommended Dosage: “Instill one drop of MIEBO four times daily into affected eye(s).”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
No safety-critical claims beyond indication and dosing were made; both are label-supported.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement